Percutaneous pulmonary valve replacement

Progress in Pediatric Cardiology

Volumn 33, Issue 2, 2012, Pages 143-150

  Fleming, Gregory A ^a   Hill, Kevin D ^a   Green, Amanda S ^a   Rhodes, John F ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Edwards SAPIEN valve; Melody valve; Percutaneous pulmonary valve; Pulmonary valve insufficiency and stenosis; Right ventricle to pulmonary artery conduit

Indexed keywords

ARTERY COMPRESSION; ARTICLE; BLOOD VESSEL CONDUIT DISSECTION; BLOOD VESSEL CONDUIT WALL RUPTURE; BLOOD VESSEL PERFORATION; CARDIOVASCULAR EQUIPMENT; CARDIOVASCULAR SURGERY; CLINICAL STUDY; CORONARY ARTERY COMPRESSION; DEVICE MALPOSITION; DEVICE SAFETY; EQUIPMENT DESIGN; HUMAN; IN-STENT RESTENOSIS; INTERMETHOD COMPARISON; PERCUTANEOUS PULMONARY VALVE REPLACEMENT; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROSTHESIS FAILURE; PULMONARY ARTERY PERFORATION; PULMONARY STENT VALVE FRACTURE; PULMONARY VALVE REPLACEMENT; STENT THROMBOSIS; SURGICAL TECHNIQUE; TRANSCATHETER PULMONARY VALVE IMPLANTATION; TREATMENT INDICATION;

EID: 84860483226     PISSN: 10589813     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ppedcard.2012.02.007     Document Type: Article

References (46)

1. Murphy J.G., Gersh B.J., Mair D.D., et al. Long-term outcome in patients undergoing surgical repair of tetralogy of Fallot. N Engl J Med 1993, 329:593-599.
2. Silka M.J., Hardy B.G., Menashe V.D., Morris C.D. A population-based prospective evaluation of risk of sudden cardiac death after operation for common congenital heart defects. J Am Coll Cardiol 1998, 32:245-251.
3. Geva T., Sandweiss B.M., Gauvreau K., Lock J.E., Powell A.J. Factors associated with impaired clinical status in long-term survivors of tetralogy of Fallot repair evaluated by magnetic resonance imaging. J Am Coll Cardiol 2004, 43:1068-1074.
4. Nollert G., Fischlein T., Bouterwek S., Bohmer C., Klinner W., Reichart B. Long-term survival in patients with repair of tetralogy of Fallot: 36-year follow-up of 490 survivors of the first year after surgical repair. J Am Coll Cardiol 1997, 30:1374-1383.
5. Kurotobi S., Taniguchi K., Sano T., et al. Determination of timing for reoperation in patients after right ventricular outflow reconstruction. Am J Cardiol 2005, 95:1344-1350.
6. Kiriazis H., Gibbs C.L., Kotsanas G., Young I.R. Mechanical and energetic changes in short-term volume and pressure overload of rabbit heart. Heart Vessels 1992, 7:175-188.
7. Chaliki H.P., Mohty D., Avierinos J.F., et al. Outcomes after aortic valve replacement in patients with severe aortic regurgitation and markedly reduced left ventricular function. Circulation 2002, 106:2687-2693.
8. Zubairi R., Malik S., Jaquiss R.D., Imamura M., Gossett J., Morrow W.R. Risk factors for prosthesis failure in pulmonary valve replacement. Ann Thorac Surg 2011, 91:561-565.
9. Peng L.F., McElhinney D.B., Nugent A.W., et al. Endovascular stenting of obstructed right ventricle-to-pulmonary artery conduits: a 15-year experience. Circulation 2006, 113:2598-2605.
10. Powell A.J., Lock J.E., Keane J.F., Perry S.B. Prolongation of RV-PA conduit life span by percutaneous stent implantation. Intermediate-term results. Circulation 1995, 92:3282-3288.
11. Therrien J., Provost Y., Merchant N., Williams W., Colman J., Webb G. Optimal timing for pulmonary valve replacement in adults after tetralogy of Fallot repair. Am J Cardiol 2005, 95:779-782.
12. Therrien J., Siu S.C., McLaughlin P.R., Liu P.P., Williams W.G., Webb G.D. Pulmonary valve replacement in adults late after repair of tetralogy of fallot: are we operating too late?. J Am Coll Cardiol 2000, 36:1670-1675.
13. Dave H.H., Buechel E.R., Dodge-Khatami A., et al. Early insertion of a pulmonary valve for chronic regurgitation helps restoration of ventricular dimensions. Ann Thorac Surg 2005, 80:1615-1620. [discussion 20-1].
14. Eyskens B., Reybrouck T., Bogaert J., et al. Homograft insertion for pulmonary regurgitation after repair of tetralogy of Fallot improves cardiorespiratory exercise performance. Am J Cardiol 2000, 85:221-225.
15. Therrien J., Siu S.C., Harris L., et al. Impact of pulmonary valve replacement on arrhythmia propensity late after repair of tetralogy of Fallot. Circulation 2001, 103:2489-2494.
16. Rebergen S.A., Chin J.G., Ottenkamp J., van der Wall E.E., de Roos A. Pulmonary regurgitation in the late postoperative follow-up of tetralogy of Fallot. Volumetric quantitation by nuclear magnetic resonance velocity mapping. Circulation 1993, 88:2257-2266.
17. Oosterhof T., van Straten A., Vliegen H.W., et al. Preoperative thresholds for pulmonary valve replacement in patients with corrected tetralogy of Fallot using cardiovascular magnetic resonance. Circulation 2007, 116:545-551.
18. Rosenhek R., Binder T., Maurer G., Baumgartner H. Normal values for Doppler echocardiographic assessment of heart valve prostheses. J Am Soc Echocardiogr 2003, 16:1116-1127.
19. Warnes C.A., Williams R.G., Bashore T.M., et al. ACC/AHA 2008 guidelines for the management of adults with congenital heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to develop guidelines on the management of adults with congenital heart disease). Circulation 2008, 118:e714-e833.
20. Scherptong RW, Hazekamp MG, Mulder BJ, et al. Follow-up after pulmonary valve replacement in adults with tetralogy of Fallot: association between QRS duration and outcome. J Am Coll Cardiol 2010;56:1486-1492.
21. Gatzoulis M.A., Balaji S., Webber S.A., et al. Risk factors for arrhythmia and sudden cardiac death late after repair of tetralogy of Fallot: a multicentre study. Lancet 2000, 356:975-981.
22. Gatzoulis M.A., Till J.A., Somerville J., Redington A.N. Mechanoelectrical interaction in tetralogy of Fallot. QRS prolongation relates to right ventricular size and predicts malignant ventricular arrhythmias and sudden death. Circulation 1995, 92:231-237.
23. Berul C.I., Hill S.L., Geggel R.L., et al. Electrocardiographic markers of late sudden death risk in postoperative tetralogy of Fallot children. J Cardiovasc Electrophysiol 1997, 8:1349-1356.
24. Geva T. Indications and timing of pulmonary valve replacement after tetralogy of Fallot repair. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu 2006, 11-22.
25. Forbess J.M. Conduit selection for right ventricular outflow tract reconstruction: contemporary options and outcomes. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu 2004, 7:115-124.
26. Caldarone C.A., McCrindle B.W., Van Arsdell G.S., et al. Independent factors associated with longevity of prosthetic pulmonary valves and valved conduits. J Thorac Cardiovasc Surg 2000, 120:1022-1030. [discussion 31].
27. Razzouk A.J., Williams W.G., Cleveland D.C., et al. Surgical connections from ventricle to pulmonary artery. Comparison of four types of valved implants. Circulation 1992, 86:II154-II158.
28. Tweddell J.S., Pelech A.N., Frommelt P.C., et al. Factors affecting longevity of homograft valves used in right ventricular outflow tract reconstruction for congenital heart disease. Circulation 2000, 102:III130-III135.
29. Dearani J.A., Danielson G.K., Puga F.J., et al. Late follow-up of 1095 patients undergoing operation for complex congenital heart disease utilizing pulmonary ventricle to pulmonary artery conduits. Ann Thorac Surg 2003, 75:399-410. [discussion -1].
30. Bonhoeffer P., Boudjemline Y., Saliba Z., et al. Percutaneous replacement of pulmonary valve in a right-ventricle to pulmonary-artery prosthetic conduit with valve failure. Lancet 2000, 356:1403-1405.
31. Nordmeyer J., Khambadkone S., Coats L., et al. Risk stratification, systematic classification, and anticipatory management strategies for stent fracture after percutaneous pulmonary valve implantation. Circulation 2007, 115:1392-1397.
32. Nordmeyer J., Lurz P., Khambadkone S., et al. Pre-stenting with a bare metal stent before percutaneous pulmonary valve implantation: acute and 1-year outcomes. Heart 2011, 97:118-123.
33. McElhinney DB, Cheatham JP, Jones TK, et al. Stent Fracture, Valve Failure, and Right Ventricular Outflow Tract Reintervention After Transcatheter Pulmonary Valve Implantation: Patient-Related and Procedural Risk Factors in the US Melody Valve Trial. Circ Cardiovasc Interv 2011;4(6):602-14.
34. Lurz P., Coats L., Khambadkone S., et al. Percutaneous pulmonary valve implantation: impact of evolving technology and learning curve on clinical outcome. Circulation 2008, 117:1964-1972.
35. McElhinney D.B., Hellenbrand W.E., Zahn E.M., et al. Short- and medium-term outcomes after transcatheter pulmonary valve placement in the expanded multicenter US melody valve trial. Circulation 2010, 122:507-516.
36. Kenny D, Hijazi ZM, Kar S, et al. Percutaneous Implantation of the Edwards SAPIEN Transcatheter Heart Valve for Conduit Failure in the Pulmonary Position: Early Phase 1 Results From an International Multicenter Clinical Trial. J Am Coll Cardiol 2011;58(21):2248-56.
37. Boone RH, Webb JG, Horlick E, et al. Transcatheter pulmonary valve implantation using the edwards SAPIEN™ transcatheter heart valve. Catheter Cardiovasc Intervent 2010;75(2):286-94.
38. Gurvitch R, Wood DA, Tay EL, et al. Transcatheter aortic valve implantation: durability of clinical and hemodynamic outcomes beyond 3 years in a large patient cohort. Circulation 2010;122:1319-1327.
39. Webb J, Cribier A. Percutaneous transarterial aortic valve implantation: what do we know? Eur Heart J 2011;32(2):140-7.
40. Leon MB, Smith CR, Mack M, et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med 2010;363(17):1597-607.
41. Cribier A., Eltchaninoff H., Tron C., et al. Treatment of calcific aortic stenosis with the percutaneous heart valve: mid-term follow-up from the initial feasibility studies: the French experience. J Am Coll Cardiol 2006, 47:1214-1223.
42. Cubeddu RJ, Hijazi ZM. Bailout perventricular pulmonary valve implantation following failed percutaneous attempt using the Edwards Sapien transcatheter heart valve. Catheter Cardiovasc Interv 2011;77(2):276-80.
43. McElhinney DB, Hellenbrand WE, Zahn EM, et al. Short- and medium-term outcomes after transcatheter pulmonary valve placement in the expanded multicenter US melody valve trial. Circulation 2010;122:507-516.
44. Khambadkone S., Coats L., Taylor A., et al. Percutaneous pulmonary valve implantation in humans: results in 59 consecutive patients. Circulation 2005, 112:1189-1197.
45. Momenah T.S., El Oakley R., Al Najashi K., Khoshhal S., Al Qethamy H., Bonhoeffer P. Extended application of percutaneous pulmonary valve implantation. J Am Coll Cardiol 2009, 53:1859-1863.
46. Schievano S, Taylor AM, Capelli C, et al. First-in-man implantation of a novel percutaneous valve: a new approach to medical device development. EuroIntervention 2010;5(6):745-50.